Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Larkspur Biosciences is a biotechnology business that is developing the next generation of precision immunotherapies to combat cancer.
Delphia Therapeutics operates and manages a laboratory that develops treatments for cancer cells.
Livara Health is a provider of non-operative, personalized treatment for musculoskeletal conditions.
ByHeart is a baby nutrition company with FDA-registered infant formula.
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Thirty Madison provides virtual healthcare and treatment for a portfolio of chronic conditions through its brands
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Vita Health delivers quality mental health care to adolescents and transitional age youth.
SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.
Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.
Crossbow Therapeutics is a biotech company that develops targeted therapies to address cancer antigens.
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.
Paratus Sciences is dedicated to advancing human health and health security by comprehending the biology of bats.
Quartet Health is a platform that makes it easier for people to get the best mental health care for them.
Indomo is a clinical-stage firm that aims to improve access to quality healthcare through novel device-enabled treatments.
FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
Be Me Health is a mobile platform that focuses on the mental health and emotional well-being of teens.
Allstacks develops a software engineering intelligence platform to predict forecasting and risk management.
Over millions and millions of years, a collection of reward systems
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.
Simon Data is the creator of a customer data platform that allows marketers to create complicated client categories.
Polaris Partners has invested in 186 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Polaris Partners's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Wellness. The firm invests across 34 different industry categories.
Among tracked funding rounds, Tome Biosciences received $213.0M in a Series A round. Polaris Partners's total known invested capital is $7.2B.
Polaris Partners's average investment size is $53.1M across its portfolio of 186 companies.
Recent Polaris Partners portfolio additions include Larkspur Biosciences, Delphia Therapeutics, Livara Health, ByHeart, Neumora Therapeutics. These companies were founded in 2020 or later.